Maybe I am wrong but wasn’t it implied that sending the small subdivision of 62 people in the CD-12 trial to all regulatory agencies with the new small data set might get us a EUA somewhere? But later retracted that India wouldn’t accept it and that a trial would need to take place. Maybe in both Brazil and Philippines too. He just didn’t know if the CD-12 data would get us anywhere but stating that they were sending it everywhere must mean they are hopeful that it could or maybe just reduce the size of trial to something comparable to that 30 person trial mentioned for that other MAB that didn’t work out. So that info may help or it may not is what I took away from the web call. There is still hope for quick approval based on CD-12 information. I wouldn’t hold my breath waiting for it.